Paul Wachter, Director at Avalanche Biotechnologies, Inc. (AAVL), sold 1,192 shares at $40.74 ($47K) on 2015-04-13, disclosed to the SEC on 2015-04-15.
Scheduled sale ($47k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.10 | 830 | $32K | 69.2% |
| 2 | $39.85 | 338 | $13K | 28.7% |
| 3 | $40.74 | 24 | $978 | 2.1% |
| Total | $39.35 avg | 1,192 | $47K | 100% |
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |